Atlas Trials

Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

Clinical trial NCT03471117 · TERMINATED

Trial details

NCT number
NCT03471117
Sponsor
The University of Texas at Arlington
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Kidney Diseases
Start date
2018-04-01
Primary completion
2020-01-14
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.